Angiogenesis in cancer and other diseases
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of vascularization is one of the landmarks of tumor environments [57,180].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [180]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundMechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162 · cited 1×
“We now know there are various molecular players involved in these different mechanisms of vascular growt”
BackgroundSelf-citationAbnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345 · cited 1×
“This hypothesis formed the basis of the discovery of angiostatin, endostatin, vasculostatin and other endogenous inhibitors of angiogenesi”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 1×
“However, caution is warranted as these hypoxia-inducible factors could also control cell deat”
BackgroundSelf-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Self-citationCancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054 · cited 1×
“In vivo selection of phage display libraries has recently yielded peptides (for example, amino-acid sequences RGD and NGR) that preferentially recognize vessels in subcutaneous tumours in mic”
BackgroundOpenings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Self-citationHelmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Self-citation
Research works printed but not linked: 8
- Greenblatt, M. & Shubik, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparant chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
- Ehrmann, R. L. & Knoth, M. Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch studied by light and electron microscopy. J. Natl Cancer Inst. 41, 1329 –1341 (1968).
- Folkman, J. in Cancer Medicine (eds Holland, J. F. et al.) 132– 152 (Decker, Ontario, Canada, 2000).
- Chang, Y. S. et al. Abundance of neoplastic cells in vessel walls of human tumor xenografts. Proc. Am. Assoc. Cancer Res. (in the press).
- Seljelid, R., Jozefowski, S. & Sveinbjornsson, B. Tumor stroma. Anticancer Res. 19, 4809–4822 (1999).
- Buschmann, I. & Schaper, W. The pathophysiology of the collateral circulation (arteriogenesis). J. Pathol. 190, 338–342 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<338::aid-path594>3.0.co;2-7
- Carmeliet, P. & Collen, D. Transgenic mouse models in angiogenesis and cardiovascular disease. J. Pathol. 190, 387–405 (2000). · doi:10.1002/(sici)1096-9896(200002)190:3<387::aid-path595>3.0.co;2-r
- Tsuzuki, Y. et al. VEGF modulation by targeting HIF-1alpha/HRE/VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. (in the press).
Cited by
Items 401–500 of 1,084
Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
Cao, Y. (2009) · Science Signaling · doi:10.1126/scisignal.259re1 · Cited by 289
“Furthermore, the impairment of VEGF-regulated vascular functions may contribute to the onset, development, and progression of several common and lethal human diseases, including cancer, cardiovascular disorders, diabetic complications, retinal degeneration, and chronic inflammation (5).”
BackgroundSeno, H., Oshima, M., Ishikawa, T., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., & Taketo, M. M. (2002) · PubMed · Cited by 326
Fuchs, C. S., Shitara, K., Di Bartolomeo, M., Lonardi, S., Al-Batran, S.-E., Van Cutsem, E., Ilson, D. H., Alsina, M., Chau, I., Lacy, J., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30791-5 · Cited by 288
Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications
De Palma, M., Murdoch, C., Venneri, M. A., Naldini, L., & Lewis, C. E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.004 · Cited by 287
Manohar, S., Vaartjes, S. E., van Hespen, J. C. G., Klaase, J. M., van den Engh, F. M., Steenbergen, W., & van Leeuwen, T. G. (2007) · Optics Express · doi:10.1364/oe.15.012277 · Cited by 287
Interstitial Flow as a Guide for Lymphangiogenesis
Boardman, K. C., & Swartz, M. A. (2003) · Circulation Research · doi:10.1161/01.res.0000065621.69843.49 · Cited by 286
Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization.
Okamoto, K., Ikemori-Kawada, M., Jestel, A., von König, K., Funahashi, Y., Matsushima, T., Tsuruoka, A., Inoue, A., & Matsui, J. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500394m · Cited by 285
Li, A., Varney, M. L., Valasek, J., Godfrey, M., Dave, B. J., & Singh, R. K. (2005) · Angiogenesis · doi:10.1007/s10456-005-5208-4 · Cited by 285
“Degradation of the extracellular matrix by MMPs is required in endothelial cell migration, organization and hence, angiogenesis [3, 4, 48, 49].”
BackgroundNegative and positive regulation of HIF-1: A complex network
Bárdos, J. I., & Ashcroft, M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.05.001 · Cited by 285
In situ force mapping of mammary gland transformation
Lopez, J. I., Kang, I., You, W.-K., McDonald, D. M., & Weaver, V. M. (2011) · Integrative Biology · doi:10.1039/c1ib00043h · Cited by 284
Cathepsin L is required for endothelial progenitor cell–induced neovascularization
Urbich, C., Heeschen, C., Aicher, A., Sasaki, K.-I., Bruhl, T., Farhadi, M. R., Vajkoczy, P., Hofmann, W. K., Peters, C., Pennacchio, L. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1182 · Cited by 284
“Postnatal blood vessel formation was formerly thought to be attributed mainly to the migration and proliferation of preexisting, fully differentiated endothelial cells, a process referred to as angiogenesi”
BackgroundUp-down regulation of HIF-1α in cancer progression
Rashid, M., Zadeh, L. R., Baradaran, B., Molavi, O., Ghesmati, Z., Sabzichi, M., & Ramezani, F. (2021) · Gene · doi:10.1016/j.gene.2021.145796 · Cited by 283
Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction
Ishii, G., Sangai, T., Oda, T., Aoyagi, Y., Hasebe, T., Kanomata, N., Endoh, Y., Okumura, C., Okuhara, Y., Magae, J., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01544-4 · Cited by 281
Vascular Endothelial Growth Factor Localization in the Adult
Maharaj, A. S. R., Saint-Geniez, M., Maldonado, A. E., & D'Amore, P. A. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050834 · Cited by 281
“VEGF is also important in the control of physiological angiogenesis, such as wound healing,(3) and in pathological angiogenesis, including tumor vascularization and neovascularization associated with a number of ocular diseases.(4,5) During development, VEGF is critical for vasculogenesis, the process by which endothe…”
Xu, L., Fukumura, D., & Jain, R. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108347200 · Cited by 281
Self-citationDistler, O., del Rosso, A., Giacomelli, R., Cipriani, P., Conforti, M. L., Guiducci, S., Gay, R. E., Michel, B. A., Brühlmann, P., Müller-Ladner, U., et al. (2002) · Arthritis Research & Therapy · doi:10.1186/ar596 · Cited by 281
“Numerous studies have shown that VEGF plays a crucial role in the formation of tumor vessels, which are in turn critical for nourishment and growth of these tumors [ 24 ,25].”
BackgroundDormond, O., Foletti, A., Paroz, C., & Rüegg, C. (2001) · Nature Medicine · doi:10.1038/nm0901-1041 · Cited by 281
“Many molecules mediating tumor angiogenesis have been identified and characterized in recent years, including vascular endothelial growth factor (VEGF), VEGF receptors, angiopoietins, Tie receptors, integrin-adhesion molecules and matrix proteinase”
BackgroundRole of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R. D., Deane, R., Brooks, A. I., Kanagala, S., Rubio, A., Sagare, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1287 · Cited by 280
Burns, A., Sengupta, P., Zedayko, T., Baird, B., & Wiesner, U. (2006) · Small · doi:10.1002/smll.200600017 · Cited by 280
beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran, V., Lee, S. H., Inge, L. J., Guo, L., Goldbeck, C., Garrett, E. N., Wiesmann, M., García, P. D., Fuller, J. H., Chan, V. W.-F., et al. (2003) · PubMed · Cited by 334
Interferon-α as an immunotherapeutic protein
Brassard, D. L., Grace, M. J., & Bordens, R. W. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.565 · Cited by 223
Kuenen, B. C., Rosen, L. S., Smit, E. F., Parson, M., Levi, M. M., Ruijter, R., Huisman, H., Kedde, M. A., Noordhuis, P., van der Vijgh, W. J. F., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1657 · Cited by 279
Vascular Endothelial Growth Factor Induction of the Angiogenic Phenotype Requires Ras Activation
Meadows, K. N., Bryant, P., & Pumiglia, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108069200 · Cited by 278
Recent advances in microfluidic technologies for cell-to-cell interaction studies
Rothbauer, M., Zirath, H., & Ertl, P. (2018) · Lab on a Chip · doi:10.1039/c7lc00815e · Cited by 277
3D Multi-Cell Simulation of Tumor Growth and Angiogenesis
Shirinifard, A., Gens, J. S., Zaitlen, B. L., Popławski, N. J., Swat, M., & Glazier, J. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007190 · Cited by 277
“Normal tumor cells become hypoxic when the oxygen partial pressure (pO2) is less than 5 mmHg [22,50,62] and become necrotic when pO2 drops below 1 mmHg.”
BackgroundMammalian Tumor Xenografts Induce Neovascularization in Zebrafish Embryos
Nicoli, S., Ribatti, D., Cotelli, F., & Presta, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4268 · Cited by 276
“The capacity of VE-cadherin MO to hamper tumor vascularization without affecting the development of normal embryo vasculature is in keeping with the well-known morphofunctional differences between normal and tumor blood vessels (1), and represents the proof-of-concept that MOs could be used in zebrafish embryos for th…”
BackgroundInfluentialIL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
Fahey, E., & Doyle, S. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01426 · Cited by 276
“However, aberrant angiogenesis or neovascularisation has been linked to several malignancies, including cancer, rheumatoid arthritis (RA), blindness, and psoriasis (9).”
BackgroundVascular endothelial growth factor can signal through platelet-derived growth factor receptors
Ball, S. G., Shuttleworth, C. A., & Kielty, C. M. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200608093 · Cited by 276
“VEGF-A is a crucial factor in promoting the recruitment and proliferation of vascular cells during both physiological and pathological angiogenesis and neovascularization (Pierce et al., 1995; Carmeliet and Jain, 2000).”
BackgroundJiang, Y., Huo, Z., Qi, X., Zuo, T., & Wu, Z. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0374 · Cited by 276
Molecular imaging of gliomas with PET: Opportunities and limitations
la Fougere, C., Suchorska, B., Bartenstein, P., Kreth, F.-W., & Tonn, J.-C. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor054 · Cited by 274
“Several efforts in this area of research are leading to the development of antiangiogenic molecules for cancer treatment.(44) The ability to measure blood flow noninvasively may be of importance in monitoring glioma therapies.”
BackgroundPlatelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy
Palacios-Acedo, A. L., Mège, D., Crescence, L., Dignat-George, F., Dubois, C., & Panicot-Dubois, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01805 · Cited by 273
“The vasculature in tumors is often fenestrated, facilitating the trans-endothelial transport, and exposing subendothelial factors like collagen and TF (14, 65).”
BackgroundNanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer
Giri, S., Karakoti, A., Graham, R. P., Maguire, J. L., Reilly, C. M., Seal, S., Rattan, R., & Shridhar, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054578 · Cited by 273
“This abnormal angiogenesis is required for the growth, survival, and metastasis of most solid tumors [7,8].”
BackgroundPEG conjugated VEGF siRNA for anti-angiogenic gene therapy
Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., & Park, T. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.023 · Cited by 273
Agnihotri, S., Burrell, K. E., Wolf, A., Jalali, S., Hawkins, C., Rutka, J. T., & Zadeh, G. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0203-0 · Cited by 272
Lazzari, G., Nicolas, V., Matsusaki, M., Akashi, M., Couvreur, P., & Mura, S. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.008 · Cited by 271
“Interactions with cancer cells, fibroblasts and ECM proteins are required to allow the migration and the proliferation of endothelial cells during tumor vascularization [15, 16].”
BackgroundIntravital imaging by simultaneous label-free autofluorescence-multiharmonic microscopy
You, S., Tu, H., Chaney, E. J., Sun, Y., Zhao, Y., Bower, A. J., Liu, Y.-Z., Marjanovic, M., Sinha, S., Pu, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04470-8 · Cited by 271
Hung, S.-C., Deng, W.-P., Yang, W. K., Liu, R.-S., Lee, C.-C., Su, T.-C., Lin, R.-J., Yang, D.-M., Chang, C.-W., Chen, W.-H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0876 · Cited by 268
“Recent studies have identified three main mechanisms of tumor angiogenesis: (a) existing vessel co-option (2); (b) endothelial sprouting ( 3 ); and (c) systemic recruitment of bone marrow–derived progenitor cells, including endothelial and mesenchymal progenitor cells (4).”
BackgroundDredge, K., Horsfall, R., Robinson, S. P., Zhang, L.-H., Lu, L., Tang, Y., Shirley, M. A., Muller, G., Schafer, P., Stirling, D., et al. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.01.002 · Cited by 268
Control of cell adhesion dynamics by Rap1 signaling
Boettner, B., & Van Aelst, L. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.06.004 · Cited by 268
“Also, the microvasculature in developing tumors appears to be especially refractile to mechanical stress with a compounding effect on overall tumor etiology [28].”
BackgroundRosen, L. S. (2002) · Cancer Control · doi:10.1177/107327480200902s05 · Cited by 268
Levine, H. (2001) · Bulletin of Mathematical Biology · doi:10.1006/bulm.2001.0240 · Cited by 268
Caveolae: mining little caves for new cancer targets
Carver, L. A., & Schnitzer, J. E. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1146 · Cited by 267
“Caveolae, angiogenesis and metastasis Most solid tumours require an adequate blood supply not only to survive but also to meet the metabolic needs of rapid growt”
BackgroundYang, Z.-Z., Li, J.-Q., Wang, Z.-Z., Dong, D.-W., & Qi, X.-R. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.03.017 · Cited by 267
“Angiogenesis, which plays a critical role in tumor growth and metastasis [9], is driven by vascular endothelial growth factor (VEGF).”
BackgroundCooke, J. P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00034-5 · Cited by 266
Tubeless microfluidic angiogenesis assay with three-dimensional endothelial-lined microvessels
Bischel, L. L., Young, E. W. K., Mader, B. R., & Beebe, D. J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.005 · Cited by 265
“Without new vessel formation and proper blood supply, tumor cells too distant (>w200 mm) from existing vessels would lack the supply of oxygen and nutrients essential for cell survival and proliferation [1].”
BackgroundCellular and molecular pathways linking inflammation and cancer
Porta, C., Larghi, P., Rimoldi, M., Grazia Totaro, M., Allavena, P., Mantovani, A., & Sica, A. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.06.014 · Cited by 250
“The generation of new blood vessels in response to the increasing demand for nutrients and oxygen experienced by proliferating tumour cells is essential for tumour growth and progression (Carmeliet and Jain 2000).”
Angiogenesis and invasion in glioma
Onishi, M., Ichikawa, T., Kurozumi, K., & Date, I. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-010-0007-z · Cited by 264
“VEGF-A regulates endothelial cell survival, proliferation, permeability, and migration primarily via VEGF-receptor 2 (VEGFR2) [47].”
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
Kumari, R., Sunil, D., & Ningthoujam, R. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.041 · Cited by 263
Plasminogen Activator Inhibitor-1 Regulates Tumor Growth and Angiogenesis
McMahon, G. A., Petitclerc, E., Stefansson, S., Smith, E., Wong, M. K. K., Westrick, R. J., Ginsburg, D., Brooks, P. C., & Lawrence, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105980200 · Cited by 263
Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin
Gibellini, L., Pinti, M., Nasi, M., De Biasi, S., Roat, E., Bertoncelli, L., & Cossarizza, A. (2010) · Cancers · doi:10.3390/cancers2021288 · Cited by 263
“Angiogenesis essentially involves endothelial cells and is regulated by several stimuli (hypoxia, growth factors, cytokines, and oxidative stress), which contribute to the modulation of vascular endothelial growth factor (VEGF), angiopoietin (ANG), EGF, fibroblast growth factor (FGF), transforming growth factor (TGF),…”
BackgroundZhang, L., Yang, N., Park, J.-W., Katsaros, D., Fracchioli, S., Cao, G., O’Brien-Jenkins, A., Randall, T. C., Rubin, S. C., & Coukos, G. (2003) · PubMed · Cited by 319
Nanotechnology for angiogenesis: opportunities and challenges
Kargozar, S., Baino, F., Hamzehlou, S., Hamblin, M. R., & Mozafari, M. (2020) · Chemical Society Reviews · doi:10.1039/c8cs01021h · Cited by 262
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
He, Y., Xu, W., Xiao, Y.-T., Huang, H., Gu, D., & Ren, S. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01042-7 · Cited by 261
“Angiogenesis is essential for tumor growth, because the newly formed blood vessels are important to sustain adequate energy and oxygen.(468,469) The binding of VEGFs (VEGFA, VEGFB, VEGFC, and VEGFD) to cell surface receptors (VEGFR1, VEGFR2, VEGFR3) activates signaling pathways that play important roles in cell growth…”
BackgroundOjha, T., Pathak, V., Shi, Y., Hennink, W. E., Moonen, C. T. W., Storm, G., Kiessling, F., & Lammers, T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.007 · Cited by 260
The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis
Chang, C., & Werb, Z. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82222-4 · Cited by 259
Robinet, A., Fahem, A., Cauchard, J.-H., Huet, E., Vincent, L., Lorimier, S., Antonicelli, F., Soria, C., Crepin, M., Hornebeck, W., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.01613 · Cited by 259
“Several protein families can promote angiogenesis, among which are growth factors, cytokines, integrins, proteinases, extracellular matrix components and cell adhesive proteins (Folkman, 1995; Risau, 1997; Carmeliet and Jain, 2000).”
BackgroundTherapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases
Fallah, A., Sadeghinia, A., Kahroba, H., Samadi, A., Heidari, H. R., Bradaran, B., Zeinali, S., & Molavi, O. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.022 · Cited by 259
Mulder, W. J. M., Strijkers, G. J., Habets, J. W., Bleeker, E. J. W., van der Schaft, D. W. J., Storm, G., Koning, G. A., Griffioen, A. W., & Nicolay, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-4145fje · Cited by 259
Fernandez, M., Vizzutti, F., Garcia-Pagan, J. C., Rodes, J., & Bosch, J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.012 · Cited by 259
Different strategies to overcome multidrug resistance in cancer
Saraswathy, M., & Gong, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.06.004 · Cited by 248
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities
Kirtane, A. R., Kalscheuer, S. M., & Panyam, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.001 · Cited by 258
A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors
Heeschen, C., Weis, M., Aicher, A., Dimmeler, S., & Cooke, J. P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214676 · Cited by 258
She, W., Li, N., Luo, K., Guo, C., Wang, G., Geng, Y., & Gu, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.017 · Cited by 258
“Angiogenesis, the formation of new vessels, has a major role in tumor growth, dissemination and metastasis in both solid and hematological tumors [59].”
Background(2001) · PubMed · Cited by 257
Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities
Zhang, Y., Jiang, P., Ye, M., Kim, S.-H., Jiang, C., & Lü, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131013621 · Cited by 257
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor
JAIN, R. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70063-8 · Cited by 256
Self-citationPrakash, S., Malhotra, M., Shao, W., Tomaro-Duchesneau, C., & Abbasi, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.013 · Cited by 256
“The tumor microenvironment comprises fast-growing, hyperproliferative cancer cells having a highmetabolic rate and demand for the recruitment of new vessels (neovascularization) in order to supply themwith oxygen and nutrients [54].”
BackgroundCorbacho, A., Martinez De La Escalera, G., & Clapp, C. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730219 · Cited by 256
Elastin‐Elastases and Inflamm‐Aging
Antonicelli, F., Bellon, G., Debelle, L., & Hornebeck, W. (2007) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)79005-6 · Cited by 240
Transforming growth factor-β and the hallmarks of cancer
Tian, M., Neil, J. R., & Schiemann, W. P. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2010.10.015 · Cited by 244
Tsuzuki, Y., Fukumura, D., Oosthuyse, B., Koike, C., Carmeliet, P., & Jain, R. K. (2000) · PubMed · Cited by 301
Self-citationGálvez, B. G., Matı́as-Román, S., Albar, J. P., Sánchez-Madrid, F., & Arroyo, A. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104094200 · Cited by 251
Modeling pO2 Distributions in the Bone Marrow Hematopoietic Compartment. I. Krogh's Model
Chow, D. C., Wenning, L. A., Miller, W. M., & Papoutsakis, E. T. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75732-3 · Cited by 253
“Variations in oxygen concentration (or oxygen partial pressure, pO2) in different tissues have both physiological and pathophysiological implications (Brizel et al., 1999; Carmeliet and Jain, 2000; Hansen-Algenstaedt et al., 2000; Leunig et al., 1992; Roh et al., 1991; Vaupel and Hoeckel, 1999).”
BackgroundMolecular basis of endothelial cell morphogenesis in three‐dimensional extracellular matrices
Davis, G. E., Bayless, K. J., & Mavila, A. (2002) · The Anatomical Record · doi:10.1002/ar.10159 · Cited by 253
“Angiogenesis refers to new blood vessel formation from preexisting vessels (Folkman, 1995; Hanahan, 1997; Carmeliet and Jain, 2000; Conway et al., 2001).”
BackgroundTommasino, F., & Durante, M. (2015) · Cancers · doi:10.3390/cancers7010353 · Cited by 252
“It is well known that angiogenesis is an important aspect of tumor progression [63].”
BackgroundOrganometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Nowak-Sliwinska, P., van Beijnum, J. R., Casini, A., Nazarov, A. A., Wagnières, G., van den Bergh, H., Dyson, P. J., & Griffioen, A. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002074 · Cited by 248
Cell killing by antibody–drug conjugates
Kovtun, Y. V., & Goldmacher, V. S. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.04.010 · Cited by 246
“As a potential advantage, the bystander cytotoxicity may enhance the potency of ADCs against solid tumors that express the antigen in a heterogeneous fashion, or when there are barriers to ADC access to all cells of a solid tumor [57,65].”
BackgroundGenistein: Its role in metabolic diseases and cancer
Mukund, V., Mukund, D., Sharma, V., Mannarapu, M., & Alam, A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.09.004 · Cited by 249
Sun, Y., Zhao, D., Wang, G., Wang, Y., Cao, L., Sun, J., Jiang, Q., & He, Z. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.01.004 · Cited by 250
Mechanisms of cancer metastasis
Castaneda, M., den Hollander, P., Kuburich, N. A., Rosen, J. M., & Mani, S. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.006 · Cited by 249
Scapini, P., Morini, M., Tecchio, C., Minghelli, S., Di Carlo, E., Tanghetti, E., Albini, A., Lowell, C., Berton, G., Noonan, D. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5034 · Cited by 249
“A ngiogenesis consists in the formation of new capillaries from preexisting blood vessels and is a well-known end point in chronic inflammatory diseases and in tumor progression (1).”
BackgroundInsulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo
Björndahl, M., Cao, R., Nissen, L. J., Clasper, S., Johnson, L. A., Xue, Y., Zhou, Z., Jackson, D., Jon Hansen, A., & Cao, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507865102 · Cited by 249
Structure, kinetic properties and biological function of mechanosensitive Piezo channels
Fang, X.-Z., Zhou, T., Xu, J.-Q., Wang, Y.-X., Sun, M.-M., He, Y.-J., Pan, S.-W., Xiong, W., Peng, Z.-K., Gao, X.-H., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-020-00522-z · Cited by 226
Ludwig, B. S., Kessler, H., Kossatz, S., & Reuning, U. (2021) · Cancers · doi:10.3390/cancers13071711 · Cited by 238
Chang, M., Hou, Z., Jin, D., Zhou, J., Wang, M., Wang, M., Shu, M., Ding, B., Li, C., & Lin, J. (2020) · Advanced Materials · doi:10.1002/adma.202004647 · Cited by 249
Hypoxia-Inducible Factors and Cancer
Jun, J. C., Rathore, A., Younas, H., Gilkes, D., & Polotsky, V. Y. (2017) · Current Sleep Medicine Reports · doi:10.1007/s40675-017-0062-7 · Cited by 248
Bioprinting the Cancer Microenvironment
Zhang, Y. S., Duchamp, M., Oklu, R., Ellisen, L. W., Langer, R., & Khademhosseini, A. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00246 · Cited by 248
Lane, H. A., Wood, J. M., McSheehy, P. M. J., Allegrini, P. R., Boulay, A., Brueggen, J., Littlewood-Evans, A., Maira, S.-M., Martiny-Baron, G., Schnell, C. R., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2057 · Cited by 249
Angiogenesis and Lung Cancer: Prognostic and Therapeutic Implications
Herbst, R. S., Onn, A., & Sandler, A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.18.853 · Cited by 246
Integrin Targeted Delivery of Chemotherapeutics
Chen, K., & Chen, X. (2011) · Theranostics · doi:10.7150/thno/v01p0189 · Cited by 242
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Greenberger, L. M., Horak, I. D., Filpula, D., Sapra, P., Westergaard, M., Frydenlund, H. F., Albæk, C., Schrøder, H., & Ørum, H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0510 · Cited by 245
“Solid tumors contain poorly vascularized regions associated with hypoxia and nutrient starvation (1, 2).”
BackgroundBiomaterials tools to modulate the tumour microenvironment in immunotherapy
Chao, Y., & Liu, Z. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00004-6 · Cited by 245
Bockhorn, M., Jain, R. K., & Munn, L. L. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70140-7 · Cited by 244
Self-citationSakamoto, K., Maeda, S., Hikiba, Y., Nakagawa, H., Hayakawa, Y., Shibata, W., Yanai, A., Ogura, K., & Omata, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1383 · Cited by 242
Ruzinova, M. B., Schoer, R. A., Gerald, W., Egan, J. E., Pandolfi, P. P., Rafii, S., Manova, K., Mittal, V., & Benezra, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00240-x · Cited by 244
The zebrafish/tumor xenograft angiogenesis assay
Nicoli, S., & Presta, M. (2007) · Nature Protocols · doi:10.1038/nprot.2007.412 · Cited by 242
“412" language="eng" publish="issue" relation="no"> Introduction Angiogenesis plays a key role in tumor growth and metastasi”
BackgroundRole of eNOS in neovascularization: NO for endothelial progenitor cells
Duda, D. G., Fukumura, D., & Jain, R. K. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.02.001 · Cited by 240
Self-citationAdvances in nanomedicine for cancer starvation therapy
Yu, S., Chen, Z., Zeng, X., Chen, X., & Gu, Z. (2019) · Theranostics · doi:10.7150/thno.38261 · Cited by 242
“Tumor growth and metastasis highly depend on the angiogenesis, which is an essential step of neoplasms from benign to malignant transformation [48].”
Bayless, K. J., & Davis, G. E. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.6.1123 · Cited by 242
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels
Fonsatti, E., Altomonte, M., Nicotra, M. R., Natali, P. G., & Maio, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206813 · Cited by 241
“The well-established notion that malignant tumors depend on angiogenesis to grow and metastasize (Carmeliet and Jain, 2000) has stimulated great interest on the potential clinical implications of the inhibition of tumor-associated angiogenesis (Brekken et al., 2002; Rajkumar et al., 2002;…”
Background
Metadata
- Authors
- Carmeliet, P., & Jain, R. K.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- Harvard University (US)
- ORCID
- Carmeliet, Peter
- Venue
- Nature
- Published
- 2000-09
- Volume
- 407
- Issue
- 6801
- Pages
- 249-257
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1573363574
- Cited by
- 9,070
- References
- 72
- Citations by year
- 2026: 166 · 2025: 208 · 2024: 246 · 2023: 330 · 2022: 335 · 2021: 381 · 2020: 368 · 2019: 349 · 2018: 375 · 2017: 380 · 2016: 378 · 2015: 364 · 2014: 414 · 2013: 412 · 2012: 416
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- pathological angiogenesis, cancer, ischemic diseases, inflammatory diseases, anti-angiogenic therapy, clinical trials
- MeSH terms
- Animals, Disease, Humans, Lymphokines, Neoplasms, Neovascularization, Pathologic, Endothelial Growth Factors, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.